Bio Techne Corp Stock Technical Analysis
| TECH Stock | USD 59.93 0.47 0.79% |
As of the 16th of February 2026, Bio Techne shows the Mean Deviation of 1.84, downside deviation of 2.11, and Risk Adjusted Performance of 0.0391. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Bio Techne, as well as the relationship between them.
Bio Techne Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioBio Techne's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Bio Techne Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 75.25 | Strong Buy | 15 | Odds |
Most Bio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bio Techne Corp, talking to its executives and customers, or listening to Bio conference calls.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Dividend Share 0.32 | Earnings Share 0.53 | Revenue Per Share | Quarterly Revenue Growth (0) |
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Bio Techne 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Techne's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Techne.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Bio Techne on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Techne Corp or generate 0.0% return on investment in Bio Techne over 90 days. Bio Techne is related to or competes with Moderna, Exelixis, Biomarin Pharmaceutical, Madrigal Pharmaceuticals, Avidity Biosciences, Caris Life, and Jazz Pharmaceuticals. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instrum... More
Bio Techne Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Techne's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Techne Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.11 | |||
| Information Ratio | 0.0106 | |||
| Maximum Drawdown | 12.41 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 3.74 |
Bio Techne Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Techne's standard deviation. In reality, there are many statistical measures that can use Bio Techne historical prices to predict the future Bio Techne's volatility.| Risk Adjusted Performance | 0.0391 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0119 | |||
| Treynor Ratio | 0.0548 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0391 | |||
| Market Risk Adjusted Performance | 0.0648 | |||
| Mean Deviation | 1.84 | |||
| Semi Deviation | 1.99 | |||
| Downside Deviation | 2.11 | |||
| Coefficient Of Variation | 2483.54 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.58 | |||
| Information Ratio | 0.0106 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0119 | |||
| Treynor Ratio | 0.0548 | |||
| Maximum Drawdown | 12.41 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 3.74 | |||
| Downside Variance | 4.43 | |||
| Semi Variance | 3.97 | |||
| Expected Short fall | (2.11) | |||
| Skewness | 0.2915 | |||
| Kurtosis | 0.3482 |
Bio Techne Corp Backtested Returns
Bio Techne is very steady at the moment. Bio Techne Corp secures Sharpe Ratio (or Efficiency) of 0.0335, which signifies that the company had a 0.0335 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bio Techne Corp, which you can use to evaluate the volatility of the firm. Please confirm Bio Techne's Downside Deviation of 2.11, risk adjusted performance of 0.0391, and Mean Deviation of 1.84 to double-check if the risk estimate we provide is consistent with the expected return of 0.0788%. Bio Techne has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.55, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Techne will likely underperform. Bio Techne Corp right now shows a risk of 2.35%. Please confirm Bio Techne Corp expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Bio Techne Corp will be following its price patterns.
Auto-correlation | 0.43 |
Average predictability
Bio Techne Corp has average predictability. Overlapping area represents the amount of predictability between Bio Techne time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Techne Corp price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Bio Techne price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 9.19 |
Bio Techne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Bio Techne Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Bio Techne Corp across different markets.
About Bio Techne Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bio Techne Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bio Techne Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bio Techne Corp price pattern first instead of the macroeconomic environment surrounding Bio Techne Corp. By analyzing Bio Techne's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bio Techne's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bio Techne specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.004464 | 0.006218 | 0.00715 | 0.0106 | Price To Sales Ratio | 9.74 | 6.64 | 5.98 | 6.86 |
Bio Techne February 16, 2026 Technical Indicators
Most technical analysis of Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bio from various momentum indicators to cycle indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0391 | |||
| Market Risk Adjusted Performance | 0.0648 | |||
| Mean Deviation | 1.84 | |||
| Semi Deviation | 1.99 | |||
| Downside Deviation | 2.11 | |||
| Coefficient Of Variation | 2483.54 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.58 | |||
| Information Ratio | 0.0106 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0119 | |||
| Treynor Ratio | 0.0548 | |||
| Maximum Drawdown | 12.41 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 3.74 | |||
| Downside Variance | 4.43 | |||
| Semi Variance | 3.97 | |||
| Expected Short fall | (2.11) | |||
| Skewness | 0.2915 | |||
| Kurtosis | 0.3482 |
Bio Techne February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 0.23 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 60.11 | ||
| Day Typical Price | 60.05 | ||
| Price Action Indicator | 0.06 | ||
| Market Facilitation Index | 2.07 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |